Drug
Tivdak
Tivdak: highest development phase Post-Market, developed by Pfizer. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| TIVDAK NCT06952660 | Post-Market | Cervical Cancer |
Latest
No recent events.
Follow Tivdak on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.